Clinical and prognostic effects of CDKN2A , CDKN2B and CDH13 promoter methylation in ovarian cancer: a study using meta-analysis and TCGA data

Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals
Liang XiaLi Gao

Abstract

Background: Promoter methylation of tumour suppressor genes (TSGs) CDKN2A, CDKN2B and CDH13 has been reported in ovarian cancer. However, the clinicopathological characteristics and prognostic role of CDKN2A, CDKN2B and CDH13 promoter methylation in ovarian carcinoma remained unclear. Methods: The pooled odds ratio (OR) or hazard ratios (HRs) with their 95% confidence intervals (95% CIs) were calculated in this meta-analysis. The Cancer Genome Atlas data were obtained to confirm the role of CDKN2A, CDKN2B and CDH13 methylation in ovarian cancer. Results:CDKN2A, CDKN2B and CDH13 promoter methylation was higher in ovarian cancer than in normal ovarian tissues. CDH13 promoter methylation was correlated with tumour histology (serous vs. non-serous type: OR = 0.33, p = 0.031). CDKN2A promoter methylation was not linked to overall survival (OS), but it was correlated with a poor prognosis in progression-free survival (HR = 1.55, p = 0.004). TCGA data showed no correlation between CDKN2A, CDKN2B and CDH13 methylation and OS as well as disease-free survival (DFS). Conclusions:CDKN2A, CDKN2B and CDH13 promoter methylation may correlate with the increased risk of ovarian cancer. CDKN2A promoter methylation may be an independent prognosti...Continue Reading

References

Mar 4, 1997·International Journal of Cancer. Journal International Du Cancer·Y C ShihG Chenevix-Trench
Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
Feb 12, 1998·Annals of Internal Medicine·J LauC H Schmid
Jun 4, 1999·Cancer Letters·Y F WongA M Chang
Jul 17, 1999·British Journal of Cancer·R NakashimaY Murata
Sep 22, 2001·Human Pathology·Y HashiguchiS Ogita
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Sep 27, 2003·Annals of Hematology·C S ChimY L Kwong
Nov 25, 2003·The New England Journal of Medicine·James G Herman, Stephen B Baylin
Dec 14, 2004·The New England Journal of Medicine·Stephen A Cannistra
Jul 8, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Zhensheng LiuQingyi Wei
Aug 3, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Prakash B MakarlaJohn O Schorge
Dec 21, 2006·Journal of Cancer Research and Clinical Oncology·K F TamH Y S Ngan
Sep 2, 2008·Gynecologic Oncology·Qinghua FengNancy Kiviat
Oct 14, 2008·The International Journal of Biochemistry & Cell Biology·Paco Hulpiau, Frans van Roy
Apr 8, 2009·International Journal of Epidemiology·Michael D Coory
Jul 22, 2009·PLoS Medicine·David MoherUNKNOWN PRISMA Group
May 22, 2010·European Journal of Clinical Investigation·Chih-Ming HoShwu-Fen Chang
Feb 22, 2012·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Lakshmi Sowjanya BammidiRudrama Devi Kanapuram
Dec 12, 2012·Experimental and Therapeutic Medicine·Filiz OzdemirNur Buyru
Apr 11, 2013·Toxicology and Industrial Health·Said S MoselhyAshraf Dalol
May 15, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ronald L Korn, John J Crowley
Jun 11, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Rahul BhagatLakshmi Krishnamoorthy
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Feb 24, 2015·Biochimica Et Biophysica Acta·Halima Ouadid-AhidouchAhmed Ahidouch
Dec 3, 2015·World Journal of Biological Chemistry·Shafqat Ali KhanSanjay Gupta
Nov 1, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Iris J H van VlodropManon van Engeland
Jan 6, 2017·Cancer Research and Treatment : Official Journal of Korean Cancer Association·Shahid M BabaSheikh A Aziz

❮ Previous
Next ❯

Citations

Jul 1, 2020·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Y LuanJ Mao
Feb 16, 2021·Neurosurgery·Angus TolandSonika M Dahiya

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.